Stock market crash! Why I’d buy these 2 cheap UK dividend shares now for a passive income

Buying these two UK dividend shares after the recent stock market crash could be a means of obtaining a passive income in my view.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

The stock market crash may have led some investors to avoid UK dividend shares to try to make a passive income. Their volatile recent performances may mean that cash and bonds offer a more stable return.

However, with dividend yields among UK shares being relatively high, they may appeal to an income investor. Meanwhile, low interest rates mean that cash and bonds may offer sub-inflation rates of return.

With that in mind, here are two FTSE 100 shares that appear to offer generous dividend prospects and low valuations that could lead to impressive long-term returns.

A defensive stock that offers a stable passive income

FTSE 100-listed GSK (LSE: GSK) may not be an obvious choice for an investor who is seeking to make a passive income after the stock market crash. After all, the healthcare company has failed to increase its dividend on a per share basis over recent years.

However, its recent updates have shown that it has delivered relatively resilient financial performance during a challenging period for the world economy. For example, its recent third-quarter update showed that it is on track to meet earnings guidance for the full year. This is despite disruption from coronavirus impacting negatively on its vaccine division.

GSK’s share price fall of 25% since the start of the year means that it now has a dividend yield of around 5.8%. That’s above the FTSE 100’s yield of 4.7%, and suggests that it may become an increasingly attractive means for an investor to make a passive income.

Certainly, there is likely to be further disruption to the company’s business model. There may even be a second stock market crash that impacts negatively on its share price. However, its track record of relative outperformance during a weak economic environment may make it an attractive income opportunity.

A growing UK dividend share

British American Tobacco (LSE: BATS) is another UK dividend share that could provide a relatively resilient passive income. The company recently announced that it has maintained its financial guidance for the current year despite some disruption caused by coronavirus.

Moreover, it continues to expect to pay out around 65% of its net profit as a dividend. This means that in the next financial year the company is expected to yield over 9%.

Certainly, BATS faces a challenging future as consumers gradually switch towards less harmful products. However, it now generates around 10% of its sales from non-combustible products and plans to invest heavily in cigarette alternatives. This could help to improve its financial prospects while cigarette volumes are declining.

Of course, there may be more popular UK dividend shares than BATS for investors who are looking to make a passive income. However, the progress it is making in implementing its revised strategy could help it to deliver a sound total return over the long run.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Peter Stephens owns shares of British American Tobacco and GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »